Emergent Biosolutions, Inc. (EBS)
PHARMACEUTICAL PREPARATIONS
Emergent Biosolutions, Inc. (EBS) is listed on the New York Stock Exchange, where it has traded since November 15, 2006.
- Listed On
- the New York Stock Exchange
- Listed Since
- November 15, 2006
- Employees
- 900
- Market Cap
- $355M
About Emergent Biosolutions, Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 189 institutions reported holding EBS, with 43.5 million shares worth $364.7 million in aggregate. The largest reported holder was BlackRock, with 4.7 million shares worth $39.5 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 4,716,599 | $40M | Added 8.64% |
| Vanguard | 3,635,158 | $30M | Reduced 6.6% |
| Dimensional Fund Advisors | 3,076,646 | $26M | Added 11.59% |
| State Street | 2,929,238 | $25M | Added 2.79% |
| American Century Companies | 2,770,448 | $23M | Added 14.21% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is EBS?
Emergent Biosolutions, Inc. (EBS) is listed on the New York Stock Exchange, where it has traded since November 15, 2006.
Who are the largest institutional holders of EBS?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of EBS were BlackRock, Vanguard and Dimensional Fund Advisors.
How many institutions own EBS?
189 institutions reported a position in EBS for the quarter ended June 30, 2026, worth $364.7 million in total.
Did institutions buy or sell EBS last quarter?
Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for EBS.
Every reported institutional holder, plus insider and congressional trades in EBS, on SentiSense.